Biomarcadores de respuesta a la inmunoterapia y a otros tratamientos en la práctica clínica asistencial: Retos y perspectivas de futuro

Anti-tumor immune responses were assessed and were compared to the composition of the gut (fecal) microbiome in patients on anti-PD-1

Presented By Jennifer Wargo at 2017 ASCO Annual Meeting

Gut microbiome & CPIs efficacy